Dyne Therapeutics (NASDAQ: DYN) has recently received a number of price target changes and ratings updates: 12/15/2025 – Dyne Therapeutics had its price target lowered by analysts at Evercore ISI from $38.00 to $36.00. They now have an “outperform” rating on the stock. 12/11/2025 – Dyne Therapeutics had its price target raised by analysts at [...]
Analysts’ Recent Ratings Changes for Dyne Therapeutics (DYN)
